Drug_Name,STUDYID,YEAR,Country,Dataset,Patient_Count,Median_Age,Female_Percentage,Male_Percentage,Median_BMI,Smoking_History_Yes_Percentage,Total_ADL_Independence_Percentage,LHRH_Use_Percentage,Tumor_Stage_T1_Percentage,Tumor_Stage_T2_Percentage,Tumor_Stage_T3_Percentage,Tumor_Stage_T4_Percentage,Nodal_Stage_N0_Percentage,Nodal_Stage_N1_Percentage,Nodal_Stage_N2_Percentage,Nodal_Stage_N3_Percentage,Stage_I_Percentage,Stage_II_Percentage,Stage_III_Percentage,Diabetes_Mellitus_Percentage,Congestive_Heart_Failure_Percentage,Stroke_Percentage,Atrial_Fibrillation_Percentage,Myocardial_Infarction_Percentage,Neoadjuvant_Chemotherapy_Received_Percentage,Adjuvant_Chemotherapy_Received_Percentage,Postoperative_RT_Received_Percentage,Common_Neoadjuvant_Regimen_1,Common_Neoadjuvant_Regimen_2,Common_Adjuvant_Regimen_1,Common_Adjuvant_Regimen_2,Tamoxifen_Percentage,Letrozole_Percentage,Anastrozole_Percentage,Antidiarrheal_Agent_Probiotics_Percentage,Antiemetic_Agent_Percentage,Painkiller_Antipyretic_Percentage,Beds_Less_Than_200_Percentage,Beds_200_To_499_Percentage,Beds_Greater_Or_Equal_To_500_Percentage,Designated_Cancer_Hospital_Percentage,Months_Between_Surgery_And_Index_Date
Tamoxifen,TAMO101,2018,USA,MDV,350,62,99.5,0.5,27.5,18.2,85.1,5.3,25.6,45.2,20.1,9.1,60.3,25.7,10.2,3.8,30.5,40.2,20.3,12.5,4.2,2.1,6.3,3.5,15.4,55.2,65.3,AC,TC,CMF,Taxol,80.5,8.2,6.3,15.2,25.3,35.4,15.2,45.3,39.5,60.2,1.5
Tamoxifen,TAMO202,2019,Canada,Claim Database,420,68,99.1,0.9,28.1,21.5,78.6,7.8,28.7,42.3,18.9,10.1,58.2,27.1,11.5,3.2,32.1,38.5,19.7,14.8,5.9,2.8,7.5,4.1,13.2,52.9,62.4,AC,FEC,CMF,Docetaxel,75.3,10.5,7.9,17.8,28.1,38.5,12.5,42.8,44.7,65.4,2.0
Tamoxifen,TAMO303,2020,UK,MDV,280,70,98.9,1.1,29.5,25.3,75.2,9.5,30.5,40.1,17.2,12.2,55.1,29.5,12.8,2.6,33.7,36.8,18.5,16.2,7.1,3.5,8.7,4.8,11.5,50.6,60.1,EC,FEC,CMF,Cyclophosphamide,70.2,12.8,9.5,20.1,30.5,40.2,10.3,40.5,49.2,70.5,2.5
Tamoxifen,TAMO404,2021,Australia,Claim Database,480,65,99.3,0.7,26.8,15.8,88.4,6.2,23.4,47.5,19.3,9.8,62.5,24.3,9.6,3.6,31.2,41.8,19.1,11.2,3.8,1.9,5.9,3.2,16.5,56.8,66.5,AC,Taxol,CMF,FEC,82.7,7.1,5.2,14.5,24.6,34.7,16.8,46.5,36.7,58.9,1.8
Tamoxifen,TAMO505,2022,Germany,MDV,310,67,99.0,1.0,28.8,20.1,80.3,8.4,27.6,43.9,18.1,10.4,59.8,26.4,11.9,1.9,32.8,39.2,18.0,13.5,5.1,2.5,6.8,3.9,14.3,54.5,64.2,EC,AC,FEC,Taxol,77.9,9.4,6.7,16.3,26.4,36.5,13.9,44.1,42.0,63.1,2.2
